Lataa...
Cardiovascular Effects of Erythropoietin: An Update
Erythropoietin (EPO) is a therapeutic product of recombinant DNA technology and it has been in clinical use as stimulator of erythropoiesis over the last two decades. Identification of EPO and its receptor (EPOR) in the cardiovascular system expanded understanding of physiological and pathophysiolog...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3907121/ https://ncbi.nlm.nih.gov/pubmed/21081221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/B978-0-12-385061-4.00009-X |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|